146 related articles for article (PubMed ID: 19106584)
1. [Hyperthermic immuno-cellular therapy-basic and clinical study].
Takeda T; Fukunaga K; Miyazawa K; Takahashi T; Takeda H; Takeda Y; Tanigawa K; Morisaki T; Yamamoto I; Hasegawa T
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2244-6. PubMed ID: 19106584
[TBL] [Abstract][Full Text] [Related]
2. [Hyperthemia enhances activated lymphocytes and molecular target therapy].
Takeda T; Hasegawa T; Miyazawa K; Yoshida K; Takeda T; Takeda H; Takahashi T; Yamamoto I; Kobayashi S
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1924-6. PubMed ID: 22202240
[TBL] [Abstract][Full Text] [Related]
3. [Successful immunotherapy combined with hyperthermia therapy for cancer patients].
Takeda T; Dong X; Takeda H; Haba A; Takeda Y
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1739-41. PubMed ID: 17212092
[TBL] [Abstract][Full Text] [Related]
4. [Multidisciplinary therapy for 984 cancer patients--hyperthermic immunotherapy].
Takeda T; Miyazawa K; Takeda T; Takeda H; Takeda Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2243-5. PubMed ID: 21224535
[TBL] [Abstract][Full Text] [Related]
5. [Hyperthermic immunotherapy was effective in 3 CR cases as the standard treatments had no effects or could not be enforced].
Takeda H; Takeda T; Kobayashi S; Takeda T
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1939-41. PubMed ID: 22202245
[TBL] [Abstract][Full Text] [Related]
6. [The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer - analyses by cancer type and recurrence form].
Takeda T; Nakamura K; Sato M; Takeda T; Tomimaru Y; Takeda H
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1261-3. PubMed ID: 25335711
[TBL] [Abstract][Full Text] [Related]
7. [The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer - 229 clinical cases].
Nakamura K; Hanazawa S; Takeda T; Sumiyoshi R; Kobayashi S; Takeda H; Takeda T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1295-7. PubMed ID: 25335722
[TBL] [Abstract][Full Text] [Related]
8. [The effect of immunotherapy and hyperthermia for advanced or recurrent head and neck cancer - 74 clinical cases].
Takeda T; Takeda H; Tanaka C; Maruhashi S; Takeda T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1283-5. PubMed ID: 25335718
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of immunotherapy enhancement in cancer therapy by hyperthermia].
Takeda T; Miyazawa K; Takeda T; Takeda H; Hasegawa T; Takeda Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1955-7. PubMed ID: 20037289
[TBL] [Abstract][Full Text] [Related]
10. [The effect of immunotherapy and hyperthermia on patients with advanced or recurrent breast cancer].
Takeda T; Takeda T; Etani M; Kobayashi S; Takeda H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1596-9. PubMed ID: 24393860
[TBL] [Abstract][Full Text] [Related]
11. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer].
Takeda T; Akita H; Takeda T; Nakamura K; Kobayashi S; Takeda H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1606-8. PubMed ID: 24393863
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused].
Takeda T; Takeda T; Kobayashi S; Takeda H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1766-9. PubMed ID: 23267880
[TBL] [Abstract][Full Text] [Related]
14. [Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients].
Takeda T; Dong X; Takeda H; Haba A; Takeda Y
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1905-7. PubMed ID: 18219848
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
16. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
Shen RN; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
[TBL] [Abstract][Full Text] [Related]
17. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.
Lehmann K; Rickenbacher A; Jang JH; Oberkofler CE; Vonlanthen R; von Boehmer L; Humar B; Graf R; Gertsch P; Clavien PA
Ann Surg; 2012 Nov; 256(5):730-7; discussion 737-8. PubMed ID: 23095616
[TBL] [Abstract][Full Text] [Related]
18. [Augmentation of therapeutic effect of adoptive immunotherapy through a synergy between transferred killer cells and host's fresh lymphocytes].
Kan N; Yamasaki S; Harada T; Satoh K; Ichinose Y; Moriguchi Y; Kodama H; Ohgaki K
Hum Cell; 1992 Sep; 5(3):236-42. PubMed ID: 1467322
[TBL] [Abstract][Full Text] [Related]
19. Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice.
Qin W; Akutsu Y; Andocs G; Suganami A; Hu X; Yusup G; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Isozaki Y; Akanuma N; Tamura Y; Matsubara H
Oncol Rep; 2014 Dec; 32(6):2373-9. PubMed ID: 25242303
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of the combined use of radiation therapy and hyperthermia].
Matsuda T; Tanaka Y; Takeshita N; Ishiwata J; Awane Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1508-14. PubMed ID: 3592696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
